DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
DeepUll has raised $56.9M in total funding. The most recent round was Series C. The last funding was announced in April 2025.
DeepUll's investors include European Investment Bank, Columbus Venture Partners, Asabys Partners, Mérieux Equity Partners, Kurma Partners.
DeepUll is headquartered in Barcelona, Spain.
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
DeepUll is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DeepUll — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/deepull. Accessed September 29, 2026.
VCBacked. (2025). DeepUll — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/deepull
{{cite web |title=DeepUll — Funding & Investors |url=https://www.vcbacked.co/company/deepull |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated